< Back to situations

[ORGANIZATION]

Quest Diagnostics

Featured in 9 tracked stories · first seen

Situations

[ACTIVE] [TECHNOLOGY] [US] [DE] [BR]

Apple Watch Series 12 and Ultra 4 launch, bugs, and privacy

15 clusters · 296 sources · last updated

Latest: Apple releases software fix for Apple Watch reboot issues

Following the ‘Surprise and Shine’ keynote on September 9, 2026, Apple detailed the capabilities of the Apple Watch Series 12 and Apple Watch Ultra 4. Both models utilize new S11 and S12 chips and run watchOS 27. The har

[ACTIVE] [TECHNOLOGY] [US] [DE] [CN]

Apple releases iOS 27 and macOS 27 with Siri AI updates

399 clusters · 1251 sources · last updated

Latest: Apple iOS 27 introduces updates to Apple Pay, CarPlay, and Siri

Apple has released its annual software suite, including iOS 27, iPadOS 27, macOS 27 ‘Golden Gate’, watchOS 27, and visionOS 27. The centerpiece is the redesigned Siri AI, powered by Apple Intelligence, which features enh

[ACTIVE] [TECHNOLOGY] [US]

Apple and WHOOP wearable health technology competition

2 clusters · 60 sources · last updated

Latest: Apple develops screenless fitness tracker prototype

The competition between Apple and WHOOP in the wearable health technology market has intensified through the integration of advanced physiological metrics and laboratory testing. WHOOP introduced its ‘Advanced Labs’ feat

[ACTIVE] [HEALTH] [US] [AU] [GB]

Advancements in Alzheimer's detection, AI, and drug access

15 clusters · 76 sources · last updated

Latest: Alzheimer's diagnosis shifts toward early detection via blood biomarkers

Research into Alzheimer's biomarkers continues to evolve, with recent findings refining the utility of blood-based testing. While plasma p-tau217 remains a key indicator, studies suggest its predictive power in symptom-f

[QUIET] [BUSINESS] [GB] [NL] [US]

Diagnostics market growth forecasts

3 clusters · 5 sources · last updated

Latest: Point-of-care testing market projected to reach $48.88 billion by 2030

The diagnostics sector continues to show strong growth projections across precision and point-of-care (PoC) segments. The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is expected

Also covered in